Antiinflammatory activity of 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles. Isomeric 4-pyridyl and 4-substituted phenyl derivatives. 1984

I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz

Isomeric 5(6)-(4-pyridyl)- and 6(5)-(4-substituted-phenyl)-2,3-dihydroimidazo[2,1-b]thiazoles were prepared by a mixed benzoin-imidazothione route, and their structures were assigned by spectral comparison to compounds of established substitution pattern. The structural assignment was confirmed by X-ray analysis. Examination of the compounds for antiinflammatory activity by an adjuvant arthritic rat assay revealed strikingly higher potencies for one analogous series than for their isomers. This selectivity was paralleled in the ability to stimulate cell-mediated immunity, as reflected in an oxazolone-induced contact sensitivity model. A drug-receptor complex is proposed that requires at least three sites of interactions.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001169 Arthritis, Experimental ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN. Adjuvant Arthritis,Arthritis, Adjuvant-Induced,Arthritis, Collagen-Induced,Arthritis, Adjuvant,Collagen Arthritis,Arthritides, Collagen,Arthritis, Collagen,Collagen Arthritides,Collagen-Induced Arthritides,Collagen-Induced Arthritis
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole

Related Publications

I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
September 1985, Journal of medicinal chemistry,
I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
October 1971, Journal of medicinal chemistry,
I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
January 1990, Drug metabolism and disposition: the biological fate of chemicals,
I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
July 1980, Il Farmaco; edizione scientifica,
I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
November 2016, Bioorganic & medicinal chemistry,
I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
May 1988, Il Farmaco; edizione scientifica,
I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
June 2010, Archiv der Pharmazie,
I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
February 2011, Tetrahedron letters,
I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
October 2023, Future medicinal chemistry,
I Lantos, and P E Bender, and K A Razgaitis, and B M Sutton, and M J DiMartino, and D E Griswold, and D T Walz
November 1980, Bollettino chimico farmaceutico,
Copied contents to your clipboard!